Dermatol. praxi. 2019;13(1):30-32 | DOI: 10.36290/der.2019.006

Treatment pyoderma gangrenosum by topical tacrolimus

MUDr. Veronika Biolková, MUDr. Andrea Marešová
Kožní oddělení, Fakultní nemocnice Ostrava

Tacrolimus (Protopic ung) belongs to the group of topical immunomodulators. Its immunosupresive effect is used to treatment
many diseases. Aim of this article is to specify its using in term of pyoderma gangrenosum.

Keywords: topical tacrolimus, Protopic ung, pyoderma gangranosum

Published: March 21, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Biolková V, Marešová A. Treatment pyoderma gangrenosum by topical tacrolimus. Dermatol. praxi. 2019;13(1):30-32. doi: 10.36290/der.2019.006.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Marzano Valerio A, Trevisan V, Lazzari R, Crosti C. Topical tacrolimusfor the treatement of localized, idopathic, newly diagnosed pyoderma gangrenosum; Jouranl of Dermatological Treatement; 2010; 21: 140-143 Go to original source... Go to PubMed...
    2. Bellini V, Simonetti S, Lisi S. Successful treatement of severe pyoderma gangrenosum with pimecrolimus cream 1%; JEADV 2008; 22, 101-136 Jouranl compilation. Go to original source... Go to PubMed...
    3. Petrášová D. Pyoderma gangrenosum; Dermatol. praxi 2013; 7(3): 134-135.
    4. Rodriguez-Cerdeira C, Sanchez-Blanco E, Molares-Vila A. Clinical Application od Developement of Nonantibiotic Macrolides That Correct Inflammation-Driven Immune Dysfuction in Inflammatory Skin Disease, Mediators of Inflammation; 2012. Go to original source...
    5. Štork J, et al. Dermatovenerologie, Praha: Galén, 2008. 502.
    6. Šebková M, Rozehnalová Z, Vojáčková N. Takrolimus v kožních indikacích. Remedia 2007; 17: 45-49.
    7. Litvik R. Tacrolimus v koncentraci 0,03% a 0,1% ve formě masti, Farmakoterapie. ISSN 1801-1209. - Roč. 4, č. Suppl.3, (2008), s. 5-10.
    8. Laurence Le Cleach MD, et al. Is Topical Monotherpy Effective for Localized Pyoderma Gangrenosum? Arch dermatol/vol 147(No.1) 2011. Go to original source... Go to PubMed...

    Return to the content


    Dermatology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.